• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Climb Bio, Inc. - Common Stock (NQ:CLYM)

    7.110 +0.130 (+1.86%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Mar 26, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 413,652
    Open 6.960
    Bid (Size) 7.120 (100)
    Ask (Size) 7.150 (6,900)
    Prev. Close 6.980
    Today's Range 6.860 - 7.200
    52wk Range 1.050 - 8.040
    Shares Outstanding 26,993,401
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Climb Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates
    From Climb Bio, Inc.
    Via GlobeNewswire
    News headline image
    Climb Bio to Present at Upcoming Investor Conferences
    From Climb Bio, Inc.
    Via GlobeNewswire

    Performance

    YTD
    +89.6%
    +89.6%
    1 Month
    +22.0%
    +22.0%
    3 Month
    +46.6%
    +46.6%
    6 Month
    +224.7%
    +224.7%
    1 Year
    +446.9%
    +446.9%

    More News

    Read More
    News headline image
    Climb Bio Announces Pipeline Progress and Strategic Priorities for 2026
    From Climb Bio, Inc.
    Via GlobeNewswire
    News headline image
    Unusual volume stocks in Tuesday's session ↗
    Via Chartmill
    News headline image
    Which stocks are moving on Monday? ↗
    Via Chartmill
    News headline image
    Monday's session: top gainers and losers ↗
    Via Chartmill
    News headline image
    Let's take a look at the stocks that are in motion in today's session. ↗
    Via Chartmill
    News headline image
    Climb Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
    From Climb Bio, Inc.
    Via GlobeNewswire
    News headline image
    Climb Bio Reports Third Quarter 2025 Financial Results and Provides Business Updates
    From Climb Bio, Inc.
    Via GlobeNewswire
    News headline image
    Climb Bio to Present at Upcoming Investor Conferences
    From Climb Bio, Inc.
    Via GlobeNewswire
    News headline image
    Climb Bio Names Adam Villa as SVP, Technical Operations and Ashley Jones as SVP, People & Workforce Strategy
    From Climb Bio, Inc.
    Via GlobeNewswire
    News headline image
    12 Health Care Stocks Moving In Monday's After-Market Session ↗
    Via Benzinga
    News headline image
    Climb Bio to Present Data at American Society of Nephrology (ASN) Kidney Week 2025
    From Climb Bio, Inc.
    Via GlobeNewswire
    News headline image
    Small-Cap Biotech Climb Bio's Lead Drug Candidate Has Larger Long-Term Opportunity ↗
    Via Benzinga
    News headline image
    This Celestica Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday ↗
    Via Benzinga
    News headline image
    Climb Bio Appoints Susan Altschuller, Ph.D., MBA as Chief Financial Officer
    From Climb Bio, Inc.
    Via GlobeNewswire
    News headline image
    Climb Bio Announces CLYM116 Preclinical Data Highlighting Potential for Best-In-Class Therapeutic for IgAN
    From Climb Bio, Inc.
    Via GlobeNewswire
    News headline image
    Climb Bio to Host Webcast Highlighting CLYM116 and the IgA Nephropathy (IgAN) Opportunity on September 29, 2025
    From Climb Bio, Inc.
    Via GlobeNewswire
    News headline image
    UPDATE – Climb Bio to Present at Upcoming September 2025 Investor Conferences
    From Climb Bio, Inc.
    Via GlobeNewswire
    News headline image
    Climb Bio to Present at Upcoming September 2025 Investor Conferences
    From Climb Bio, Inc.
    Via GlobeNewswire
    News headline image
    Climb Bio Reports Second Quarter 2025 Financial Results and Provides Business Updates
    From Climb Bio, Inc.
    Via GlobeNewswire
    News headline image
    12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
    Via Benzinga
    News headline image
    Which stocks are moving after the closing bell on Friday? ↗
    Via Chartmill
    News headline image
    Top movers in Thursday's after hours session ↗
    Via Chartmill
    News headline image
    Climb Bio Appoints Edgar D. Charles, M.D., MSc as Chief Medical Officer
    From Climb Bio, Inc.
    Via GlobeNewswire

    Frequently Asked Questions

    Is Climb Bio, Inc. - Common Stock publicly traded?
    Yes, Climb Bio, Inc. - Common Stock is publicly traded.
    What exchange does Climb Bio, Inc. - Common Stock trade on?
    Climb Bio, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Climb Bio, Inc. - Common Stock?
    The ticker symbol for Climb Bio, Inc. - Common Stock is CLYM on the Nasdaq Stock Market
    What is the current price of Climb Bio, Inc. - Common Stock?
    The current price of Climb Bio, Inc. - Common Stock is 7.110
    When was Climb Bio, Inc. - Common Stock last traded?
    The last trade of Climb Bio, Inc. - Common Stock was at 03/26/26 04:00 PM ET
    What is the market capitalization of Climb Bio, Inc. - Common Stock?
    The market capitalization of Climb Bio, Inc. - Common Stock is 191.92M
    How many shares of Climb Bio, Inc. - Common Stock are outstanding?
    Climb Bio, Inc. - Common Stock has 192M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.